Declining System Sales Drag Cepheid Q1 Revenues Down 13 Percent

The company reported a 45 percent drop in system sales for the first quarter, but a 79 percent increase in sales of its clinical tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.